[1]
Cole, G.M.; Frautschy, S.A. Docosahexaenoic acid protects from amyloid and dendritic pathology in an Alzheimer’s disease mouse model. Nutr. Health, 2006, 18(3), 249-259. [http://dx.doi.org/10.1177/026010600601800307]. [PMID: 17180870].
[2]
Small, D.H.; Cappai, R. Alois Alzheimer and Alzheimer’s disease: a centennial perspective. J. Neurochem., 2006, 99(3), 708-710. [http://dx.doi.org/10.1111/j.1471-4159.2006.04212.x]. [PMID: 17076655].
[3]
2016 Alzheimer’s disease facts and figures. Alzheimers Dement., 2016, 12(4), 459-509. [http://dx.doi.org/10.1016/j.jalz.2016.03.001]. [PMID: 27570871].
[4]
Norrara, B.; Doerl, J.G.; Guzen, F.P.; Cavalcanti, J.R.L.P.; Freire, M.A.M. Commentary: Localized vs. systematic neurodegeneration: A paradigm shift in understanding neurodegenerative diseases. Front. Syst. Neurosci., 2017, 11, 91. [http://dx.doi.org/10.3389/fnsys.2017.00091]. [PMID: 29270113].
[5]
Santos, J.R.; Gois, A.M.; Mendonça, D.M.; Freire, M.A.M. Nutritional status, oxidative stress and dementia: the role of selenium in Alzheimer’s disease. Front. Aging Neurosci., 2014, 6, 206. [http://dx.doi.org/10.3389/fnagi.2014.00206]. [PMID: 25221506].
[6]
Heneka, M.T.; O’Banion, M.K. Inflammatory processes in Alzheimer’s disease. J. Neuroimmunol., 2007, 184(1-2), 69-91. [http://dx.doi.org/10.1016/j.jneuroim.2006.11.017]. [PMID: 17222916].
[7]
Mattson, M.P. Pathways towards and away from Alzheimer’s disease. Nature, 2004, 430(7000), 631-639. [http://dx.doi.org/10.1038/nature02621]. [PMID: 15295589].
[8]
Kasper, D.; Fauci, A.; Hauser, S.; Longo, D.; Jameson, J.L.; Loscalzo, J. Harrison’s Principles of Internal Medicine, 19th ed; , 2015.
[9]
Patten, D.A.; Germain, M.; Kelly, M.A.; Slack, R.S. Reactive oxygen species: stuck in the middle of neurodegeneration. J. Alzheimers Dis., 2010, 20(Suppl. 2), S357-S367. [http://dx.doi.org/10.3233/JAD-2010-100498]. [PMID: 20421690].
[10]
Freire, M.A.M. Pathophysiology of neurodegeneration following traumatic brain injury. West Indian Med. J., 2012, 61(7), 751-755. [PMID: 23620976].
[11]
Houstis, N.; Rosen, E.D.; Lander, E.S. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature, 2006, 440(7086), 944-948. [http://dx.doi.org/10.1038/nature04634]. [PMID: 16612386].
[12]
Uttara, B.; Singh, A.V.; Zamboni, P.; Mahajan, R.T. Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Curr. Neuropharmacol., 2009, 7(1), 65-74. [http://dx.doi.org/10.2174/157015909787602823]. [PMID: 19721819].
[13]
Van Dam, D.; De Deyn, P.P. Drug discovery in dementia: the role of rodent models. Nat. Rev. Drug Discov., 2006, 5(11), 956-970. [http://dx.doi.org/10.1038/nrd2075]. [PMID: 17080031].
[14]
Sachan, A.; Singh, S.; Singh, H.K.; Shankar, P.; Kumar, D.; Sachan, A.K.; Nath, R.; Dixit, R. An experimental study to evaluate the effect of mucuna pruriens on learning and memory in mice. Int J Innov Sci Res, 2015, 4, 144-148.
[15]
Izzo, A.A.; Hoon-Kim, S.; Radhakrishnan, R.; Williamson, E.M. A critical approach to evaluating clinical efficacy, adverse events and drug interactions of herbal remedies. Phytother. Res., 2016, 30(5), 691-700. [http://dx.doi.org/10.1002/ptr.5591]. [PMID: 26887532].
[16]
Bisht, K.; Wagner, K.H.; Bulmer, A.C. Curcumin, resveratrol and flavonoids as anti-inflammatory, cyto- and DNA-protective dietary compounds. Toxicology, 2010, 278(1), 88-100. [http://dx.doi.org/10.1016/j.tox.2009.11.008]. [PMID: 19903510].
[17]
Mattson, M.P.; Son, T.G.; Camandola, S. Viewpoint: mechanisms of action and therapeutic potential of neurohormetic phytochemicals. Dose Response, 2007, 5(3), 174-186. [http://dx.doi.org/10.2203/dose-response.07-004.Mattson]. [PMID: 18648607].
[18]
Aggarwal, B.B.; Gupta, S.C.; Sung, B. Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkers. Br. J. Pharmacol., 2013, 169(8), 1672-1692. [http://dx.doi.org/10.1111/bph.12131]. [PMID: 23425071].
[19]
Di Carlo, G.; Mascolo, N.; Izzo, A.A.; Capasso, F. Flavonoids: old and new aspects of a class of natural therapeutic drugs. Life Sci., 1999, 65(4), 337-353. [http://dx.doi.org/10.1016/S0024-3205(99)00120-4]. [PMID: 10421421].
[20]
Shakibaei, M.; Harikumar, K.B.; Aggarwal, B.B. Resveratrol addiction: to die or not to die. Mol. Nutr. Food Res., 2009, 53(1), 115-128. [http://dx.doi.org/10.1002/mnfr.200800148]. [PMID: 19072742].
[21]
Hossen, M.S.; Tanvir, E.M.; Prince, M.B.; Paul, S.; Saha, M.; Ali, M.Y.; Gan, S.H.; Khalil, M.I.; Karim, N. Protective mechanism of turmeric (Curcuma longa) on carbofuran-induced hematological and hepatic toxicities in a rat model. Pharm. Biol., 2017, 55(1), 1937-1945. [http://dx.doi.org/10.1080/13880209.2017.1345951]. [PMID: 28675957].
[22]
Kita, T.; Imai, S.; Sawada, H.; Kumagai, H.; Seto, H. The biosynthetic pathway of curcuminoid in turmeric (Curcuma longa) as revealed by 13C-labeled precursors. Biosci. Biotechnol. Biochem., 2008, 72(7), 1789-1798. [http://dx.doi.org/10.1271/bbb.80075]. [PMID: 18603793].
[23]
Sandhu, A.K.; Gray, D.J.; Lu, J.; Gu, L. Effects of exogenous abscisic acid on antioxidant capacities, anthocyanins, and flavonol contents of muscadine grape (Vitis rotundifolia) skins. Food Chem., 2011, 126, 982-988. [http://dx.doi.org/10.1016/j.foodchem.2010.11.105].
[24]
Solanki, I.; Parihar, P.; Mansuri, M.L.; Parihar, M.S. Flavonoid-based therapies in the early management of neurodegenerative diseases. Adv. Nutr., 2015, 6(1), 64-72. [http://dx.doi.org/10.3945/an.114.007500]. [PMID: 25593144].
[25]
Lorenzi, H.; Matos, F.J.A. Plantas medicinais no Brasil: nativas e exóticas cultivadas., 2002. 512
[26]
Zhang, L.; Fang, Y.; Xu, Y.; Lian, Y.; Xie, N.; Wu, T.; Zhang, H.; Sun, L.; Zhang, R.; Wang, Z. Curcumin improves amyloid β-Peptide (1-42) induced spatial memory deficits through BDNF-ERK signaling pathway. PLoS One, 2015, 10(6), e0131525. [http://dx.doi.org/10.1371/journal.pone.0131525]. [PMID: 26114940].
[27]
da Costa, I.M.; Cavalcanti, J.R.L.P.; de Queiroz, D.B.; de Azevedo, E.P.; do Rêgo, A.C.M.; Araújo Filho, I.; Parente, P.; Botelho, M.A.; Guzen, F.P. Supplementation with herbal Extracts to promote behavioral and neuroprotective effects in experimental models of Parkinson’s Disease: A systematic review. Phytother. Res., 2017, 31(7), 959-970. [http://dx.doi.org/10.1002/ptr.5813]. [PMID: 28544038].
[28]
Darvesh, A.S.; Carroll, R.T.; Bishayee, A.; Novotny, N.A.; Geldenhuys, W.J.; Van der Schyf, C.J. Curcumin and neurodegenerative diseases: a perspective. Expert Opin. Investig. Drugs, 2012, 21(8), 1123-1140. [http://dx.doi.org/10.1517/13543784.2012.693479]. [PMID: 22668065].
[29]
Strimpakos, A.S.; Sharma, R.A. Curcumin: preventive and therapeutic properties in laboratory studies and clinical trials. Antioxid. Redox Signal., 2008, 10(3), 511-545. [http://dx.doi.org/10.1089/ars.2007.1769]. [PMID: 18370854].
[30]
Ahmed, T.; Gilani, A.H. Therapeutic potential of turmeric in Alzheimer’s disease: curcumin or curcuminoids? Phytother. Res., 2014, 28(4), 517-525. [http://dx.doi.org/10.1002/ptr.5030]. [PMID: 23873854].
[31]
Wright, L.E.; Frye, J.B.; Gorti, B.; Timmermann, B.N.; Funk, J.L. Bioactivity of turmeric-derived curcuminoids and related metabolites in breast cancer. Curr. Pharm. Des., 2013, 19(34), 6218-6225. [http://dx.doi.org/10.2174/1381612811319340013]. [PMID: 23448448].
[32]
Kunnumakkara, A.B.; Bordoloi, D.; Padmavathi, G.; Monisha, J.; Roy, N.K.; Prasad, S.; Aggarwal, B.B. Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases. Br. J. Pharmacol., 2017, 174(11), 1325-1348. [http://dx.doi.org/10.1111/bph.13621]. [PMID: 27638428].
[33]
Garcia-Alloza, M.; Borrelli, L.A.; Rozkalne, A.; Hyman, B.T.; Bacskai, B.J. Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model. J. Neurochem., 2007, 102(4), 1095-1104. [http://dx.doi.org/10.1111/j.1471-4159.2007.04613.x]. [PMID: 17472706].
[34]
Lim, G.P.; Chu, T.; Yang, F.; Beech, W.; Frautschy, S.A.; Cole, G.M. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J. Neurosci., 2001, 21(21), 8370-8377. [http://dx.doi.org/10.1523/JNEUROSCI.21-21-08370.2001]. [PMID: 11606625].
[35]
Park, S.Y.; Kim, H.S.; Cho, E.K.; Kwon, B.Y.; Phark, S.; Hwang, K.W.; Sul, D. Curcumin protected PC12 cells against beta-amyloid-induced toxicity through the inhibition of oxidative damage and tau hyperphosphorylation. Food Chem. Toxicol., 2008, 46(8), 2881-2887. [http://dx.doi.org/10.1016/j.fct.2008.05.030]. [PMID: 18573304].
[36]
Huang, H.C.; Chang, P.; Dai, X.L.; Jiang, Z.F. Protective effects of curcumin on amyloid-β-induced neuronal oxidative damage. Neurochem. Res., 2012, 37(7), 1584-1597. [http://dx.doi.org/10.1007/s11064-012-0754-9]. [PMID: 22476982].
[37]
Fan, C.D.; Li, Y.; Fu, X.T.; Wu, Q.J.; Hou, Y.J.; Yang, M.F.; Sun, J.Y.; Fu, X.Y.; Zheng, Z.C.; Sun, B.L. Reversal of beta-amyloid-induced neurotoxicity in PC12 cells by curcumin, the important role of ROS-mediated signaling and ERK pathway. Cell. Mol. Neurobiol., 2017, 37(2), 211-222. [http://dx.doi.org/10.1007/s10571-016-0362-3]. [PMID: 26971524].
[38]
Thapa, A.; Vernon, B.C.; De la Peña, K.; Soliz, G.; Moreno, H.A.; López, G.P.; Chi, E.Y. Membrane-mediated neuroprotection by curcumin from amyloid-β-peptide-induced toxicity. Langmuir, 2013, 29(37), 11713-11723. [http://dx.doi.org/10.1021/la4020459]. [PMID: 24004419].
[39]
Xiong, Z.; Hongmei, Z.; Lu, S.; Yu, L. Curcumin mediates presenilin-1 activity to reduce β-amyloid production in a model of Alzheimer’s disease. Pharmacol. Rep., 2011, 63(5), 1101-1108. [http://dx.doi.org/10.1016/S1734-1140(11)70629-6]. [PMID: 22180352].
[40]
Huang, H.C.; Xu, K.; Jiang, Z.F. Curcumin-mediated neuroprotection against amyloid-β-induced mitochondrial dysfunction involves the inhibition of GSK-3β. J. Alzheimers Dis., 2012, 32(4), 981-996. [http://dx.doi.org/10.3233/JAD-2012-120688]. [PMID: 22886017].
[41]
Huang, H.C.; Chang, P.; Lu, S.Y.; Zheng, B.W.; Jiang, Z.F. Protection of curcumin against amyloid-β-induced cell damage and death involves the prevention from NMDA receptor-mediated intracellular Ca2+ elevation. J. Recept. Signal Transduct. Res., 2015, 35(5), 450-457. [http://dx.doi.org/10.3109/10799893.2015.1006331]. [PMID: 26053510].
[42]
Reddy, P.H.; Manczak, M.; Yin, X.; Grady, M.C.; Mitchell, A.; Kandimalla, R.; Kuruva, C.S. Protective effects of a natural product, curcumin, against amyloid β induced mitochondrial and synaptic toxicities in Alzheimer’s disease. J. Investig. Med., 2016, 64(8), 1220-1234. [http://dx.doi.org/10.1136/jim-2016-000240]. [PMID: 27521081].
[43]
Thapa, A.; Jett, S.D.; Chi, E.Y. Curcumin attenuates Amyloid-β aggregate Ttoxicity and modulates amyloid-β aggregation pathway. ACS Chem. Neurosci., 2016, 7(1), 56-68. [http://dx.doi.org/10.1021/acschemneuro.5b00214]. [PMID: 26529184].
[44]
Yin, W.; Zhang, X.; Shi, X.; Li, Y. Curcumin protects SH-SY5Y cells from oxidative stress by up-regulating HO-1 via Phosphatidylinositol 3 Kinase/Akt/Nrf-2 and down-regulating HO-2. Mol. Neurodegener., 2012, 7(Suppl. 1), S14. [http://dx.doi.org/10.1186/1750-1326-7-S1-S14].
[45]
Xiao, Z.; Lin, L.; Liu, Z.; Ji, F.; Shao, W.; Wang, M.; Liu, L.; Li, S.; Li, F.; Bu, X. Potential therapeutic effects of curcumin: relationship to microtubule-associated proteins 2 in Aβ1-42 insult. Brain Res., 2010, 1361, 115-123. [http://dx.doi.org/10.1016/j.brainres.2010.09.019]. [PMID: 20840842].
[46]
Xiao, Z.; Zhang, A.; Lin, J.; Zheng, Z.; Shi, X.; Di, W.; Qi, W.; Zhu, Y.; Zhou, G.; Fang, Y. Telomerase: a target for therapeutic effects of curcumin and a curcumin derivative in Aβ1-42 insult in vitro. PLoS One, 2014, 9(7), e101251. [http://dx.doi.org/10.1371/journal.pone.0101251]. [PMID: 24983737].
[47]
Qin, X.Y.; Cheng, Y.; Yu, L.C. Potential protection of curcumin against intracellular amyloid beta-induced toxicity in cultured rat prefrontal cortical neurons. Neurosci. Lett., 2010, 480(1), 21-24. [http://dx.doi.org/10.1016/j.neulet.2010.05.062]. [PMID: 20638958].
[48]
Sun, Q.; Jia, N.; Wang, W.; Jin, H.; Xu, J.; Hu, H. Protective effects of astragaloside IV against amyloid beta1-42 neurotoxicity by inhibiting the mitochondrial permeability transition pore opening. PLoS One, 2014, 9(6), e98866. [http://dx.doi.org/10.1371/journal.pone.0098866]. [PMID: 24905226].
[49]
Zhang, C.; Browne, A.; Child, D.; Tanzi, R.E. Curcumin decreases amyloid-beta peptide levels by attenuating the maturation of amyloid-beta precursor protein. J. Biol. Chem., 2010, 285(37), 28472-28480. [http://dx.doi.org/10.1074/jbc.M110.133520]. [PMID: 20622013].
[50]
Zhang, C.; Browne, A.; Divito, J.R.; Stevenson, J.A.; Romano, D.; Dong, Y.; Xie, Z.; Tanzi, R.E. Amyloid-β production via cleavage of amyloid-β protein precursor is modulated by cell density. J. Alzheimers Dis., 2010, 22(2), 683-984. [http://dx.doi.org/10.3233/JAD-2010-100816]. [PMID: 20847415].
[51]
Ye, M.X.; Li, Y.; Yin, H.; Zhang, J. Curcumin: updated molecular mechanisms and intervention targets in human lung cancer. Int. J. Mol. Sci., 2012, 13(3), 3959-3978. [http://dx.doi.org/10.3390/ijms13033959]. [PMID: 22489192].
[52]
Wang, J.; Zhang, Y.J.; Du, S. The protective effect of curcumin on Aβ induced aberrant cell cycle reentry on primary cultured rat cortical neurons. Eur. Rev. Med. Pharmacol. Sci., 2012, 16(4), 445-454. [PMID: 22696871].
[53]
Shi, X.; Zheng, Z.; Li, J.; Xiao, Z.; Qi, W.; Zhang, A.; Wu, Q.; Fang, Y. Curcumin inhibits Aβ-induced microglial inflammatory responses in vitro: Involvement of ERK1/2 and p38 signaling pathways. Neurosci. Lett., 2015, 594, 105-110. [http://dx.doi.org/10.1016/j.neulet.2015.03.045]. [PMID: 25818332].
[54]
Wang, Y.; Yin, H.; Wang, L.; Shuboy, A.; Lou, J.; Han, B.; Zhang, X.; Li, J. Curcumin as a potential treatment for Alzheimer’s disease: a study of the effects of curcumin on hippocampal expression of glial fibrillary acidic protein. Am. J. Chin. Med., 2013, 41(1), 59-70. [http://dx.doi.org/10.1142/S0192415X13500055]. [PMID: 23336507].
[55]
Feng, H.L.; Dang, H.Z.; Fan, H.; Chen, X.P.; Rao, Y.X.; Ren, Y.; Yang, J.D.; Shi, J.; Wang, P.W.; Tian, J.Z. Curcumin ameliorates insulin signalling pathway in brain of Alzheimer’s disease transgenic mice. Int. J. Immunopathol. Pharmacol., 2016, 29(4), 734-741. [http://dx.doi.org/10.1177/0394632016659494]. [PMID: 27466310].
[56]
Wang, P.; Su, C.; Li, R.; Wang, H.; Ren, Y.; Sun, H.; Yang, J.; Sun, J.; Shi, J.; Tian, J.; Jiang, S. Mechanisms and effects of curcumin on spatial learning and memory improvement in APPswe/PS1dE9 mice. J. Neurosci. Res., 2014, 92(2), 218-231. [http://dx.doi.org/10.1002/jnr.23322]. [PMID: 24273069].
[57]
Hoppe, J.B.; Coradini, K.; Frozza, R.L.; Oliveira, C.M.; Meneghetti, A.B.; Bernardi, A.; Pires, E.S.; Beck, R.C.; Salbego, C.G. Free and nanoencapsulated curcumin suppress β-amyloid-induced cognitive impairments in rats: involvement of BDNF and Akt/GSK-3β signaling pathway. Neurobiol. Learn. Mem., 2013, 106, 134-144. [http://dx.doi.org/10.1016/j.nlm.2013.08.001]. [PMID: 23954730].
[58]
He, Y.; Wang, P.; Wei, P.; Feng, H.; Ren, Y.; Yang, J.; Rao, Y.; Shi, J.; Tian, J. Effects of curcumin on synapses in APPswe/PS1dE9 mice. Int. J. Immunopathol. Pharmacol., 2016, 29(2), 217-225. [http://dx.doi.org/10.1177/0394632016638099]. [PMID: 26957323].
[59]
Feng, H.L.; Fan, H.; Dang, H.Z.; Chen, X.P.; Ren, Y.; Yang, J.D.; Wang, P.W. [Neuroprotective effect of curcumin to Aβ of double transgenic mice with Alzheimer’s disease]. Zhongguo Zhongyao Zazhi, 2014, 39(19), 3846-3849. [PMID: 25612452]
[60]
Liu, Z.J.; Li, Z.H.; Liu, L.; Tang, W.X.; Wang, Y.; Dong, M.R.; Xiao, C. Curcumin attenuates beta-Amyloid-induced neuroinflammation via activation of peroxisome proliferator-activated receptor-gamma function in a rat model of Alzheimer’s disease. Front. Pharmacol., 2016, 7, 261. [http://dx.doi.org/10.3389/fphar.2016.00261]. [PMID: 27594837].
[61]
Zheng, K.; Dai, X.; Xiao, N.; Wu, X.; Wei, Z.; Fang, W.; Zhu, Y.; Zhang, J.; Chen, X. Curcumin ameliorates memory decline via inhibiting BACE1 expression and β-Amyloid Pathology in 5×FAD transgenic mice. Mol. Neurobiol., 2017, 54(3), 1967-1977. [http://dx.doi.org/10.1007/s12035-016-9802-9]. [PMID: 26910813].
[62]
Ray, B.; Bisht, S.; Maitra, A.; Maitra, A.; Lahiri, D.K. Neuroprotective and neurorescue effects of a novel polymeric nanoparticle formulation of curcumin (NanoCurc™) in the neuronal cell culture and animal model: implications for Alzheimer’s disease. J. Alzheimers Dis., 2011, 23(1), 61-77. [http://dx.doi.org/10.3233/JAD-2010-101374]. [PMID: 20930270].
[63]
Tiwari, S.K.; Agarwal, S.; Seth, B.; Yadav, A.; Nair, S.; Bhatnagar, P.; Karmakar, M.; Kumari, M.; Chauhan, L.K.; Patel, D.K.; Srivastava, V.; Singh, D.; Gupta, S.K.; Tripathi, A.; Chaturvedi, R.K.; Gupta, K.C. Curcumin-loaded nanoparticles potently induce adult neurogenesis and reverse cognitive deficits in Alzheimer’s disease model via canonical Wnt/β-catenin pathway. ACS Nano, 2014, 8(1), 76-103. [http://dx.doi.org/10.1021/nn405077y]. [PMID: 24467380].
[64]
Masters, C.L.; Selkoe, D.J. Biochemistry of amyloid β-protein and amyloid deposits in Alzheimer disease. Cold Spring Harb. Perspect. Med., 2012, 2(6), a006262. [http://dx.doi.org/10.1101/cshperspect.a006262]. [PMID: 22675658].
[65]
Zheng, X.Y. Pharmacopoeia of the Peoples Republic of China, Chinese edn.; , 2005, Vol. 1, .
[66]
Praticò, D. Evidence of oxidative stress in Alzheimer’s disease brain and antioxidant therapy: lights and shadows. Ann. N. Y. Acad. Sci., 2008, 1147, 70-78. [http://dx.doi.org/10.1196/annals.1427.010]. [PMID: 19076432].
[67]
Praticò, D. Oxidative stress hypothesis in Alzheimer’s disease: a reappraisal. Trends Pharmacol. Sci., 2008, 29(12), 609-615. [http://dx.doi.org/10.1016/j.tips.2008.09.001]. [PMID: 18838179].
[68]
Fukui, K.; Takatsu, H.; Shinkai, T.; Suzuki, S.; Abe, K.; Urano, S. Appearance of amyloid beta-like substances and delayed-type apoptosis in rat hippocampus CA1 region through aging and oxidative stress. J. Alzheimers Dis., 2005, 8(3), 299-309. [http://dx.doi.org/10.3233/JAD-2005-8309]. [PMID: 16340088].
[69]
Butterfield, D.A.; Lauderback, C.M. Lipid peroxidation and protein oxidation in Alzheimer’s disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress. Free Radic. Biol. Med., 2002, 32(11), 1050-1060. [http://dx.doi.org/10.1016/S0891-5849(02)00794-3]. [PMID: 12031889].
[70]
Abdul, H.M.; Calabrese, V.; Calvani, M.; Butterfield, D.A. Acetyl-L-carnitine-induced up-regulation of heat shock proteins protects cortical neurons against amyloid-beta peptide 1-42-mediated oxidative stress and neurotoxicity: implications for Alzheimer’s disease. J. Neurosci. Res., 2006, 84(2), 398-408. [http://dx.doi.org/10.1002/jnr.20877]. [PMID: 16634066].
[71]
Xiao, X.Q.; Wang, R.; Tang, X.C. Huperzine A and tacrine attenuate beta-amyloid peptide-induced oxidative injury. J. Neurosci. Res., 2000, 61(5), 564-569. [http://dx.doi.org/10.1002/1097-4547(20000901)61:5<564:AID-JNR11>3.0.CO;2-X]. [PMID: 10956426].
[72]
Canevari, L.; Abramov, A.Y.; Duchen, M.R. Toxicity of amyloid beta peptide: tales of calcium, mitochondria, and oxidative stress. Neurochem. Res., 2004, 29(3), 637-650. [http://dx.doi.org/10.1023/B:NERE.0000014834.06405.af]. [PMID: 15038611].
[73]
Ban, J.Y.; Jeon, S.Y.; Bae, K.; Song, K.S.; Seong, Y.H. Catechin and epicatechin from Smilacis chinae rhizome protect cultured rat cortical neurons against amyloid beta protein (25-35)-induced neurotoxicity through inhibition of cytosolic calcium elevation. Life Sci., 2006, 79(24), 2251-2259. [http://dx.doi.org/10.1016/j.lfs.2006.07.021]. [PMID: 16978655].
[74]
Fu, H.; Li, W.; Lao, Y.; Luo, J.; Lee, N.T.; Kan, K.K.; Tsang, H.W.; Tsim, K.W.; Pang, Y.; Li, Z.; Chang, D.C.; Li, M.; Han, Y. Bis(7)-tacrine attenuates beta amyloid-induced neuronal apoptosis by regulating L-type calcium channels. J. Neurochem., 2006, 98(5), 1400-1410. [http://dx.doi.org/10.1111/j.1471-4159.2006.03960.x]. [PMID: 16771827].
[75]
Swerdlow, R.H. Mitochondria in cybrids containing mtDNA from persons with mitochondriopathies. J. Neurosci. Res., 2007, 85(15), 3416-3428. [http://dx.doi.org/10.1002/jnr.21167]. [PMID: 17243174].
[76]
Bertram, L.; Tanzi, R.E. Thirty years of Alzheimer’s disease genetics: the implications of systematic meta-analyses. Nat. Rev. Neurosci., 2008, 9(10), 768-778. [http://dx.doi.org/10.1038/nrn2494]. [PMID: 18802446].
[77]
Tanzi, R.E.; Gusella, J.F.; Watkins, P.C.; Bruns, G.A.; St George-Hyslop, P.; Van Keuren, M.L.; Patterson, D.; Pagan, S.; Kurnit, D.M.; Neve, R.L. Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. Science, 1987, 235(4791), 880-884. [http://dx.doi.org/10.1126/science.2949367]. [PMID: 2949367].
[78]
Morris, R.G.; Garrud, P.; Rawlins, J.N.; O’Keefe, J. Place navigation impaired in rats with hippocampal lesions. Nature, 1982, 297(5868), 681-683. [http://dx.doi.org/10.1038/297681a0]. [PMID: 7088155].
[79]
Leibrock, J.; Lottspeich, F.; Hohn, A.; Hofer, M.; Hengerer, B.; Masiakowski, P.; Thoenen, H.; Barde, Y.A. Molecular cloning and expression of brain-derived neurotrophic factor. Nature, 1989, 341(6238), 149-152. [http://dx.doi.org/10.1038/341149a0]. [PMID: 2779653].
[80]
Lu, B.; Nagappan, G.; Lu, Y. BDNF and synaptic plasticity, cognitive function, and dysfunction. Handb. Exp. Pharmacol., 2014, 220, 223-250. [http://dx.doi.org/10.1007/978-3-642-45106-5_9]. [PMID: 24668475].
[81]
Shoba, G.; Joy, D.; Joseph, T.; Majeed, M.; Rajendran, R.; Srinivas, P.S. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med., 1998, 64(4), 353-356. [http://dx.doi.org/10.1055/s-2006-957450]. [PMID: 9619120].
[82]
Suresh, D.; Srinivasan, K. Tissue distribution & elimination of capsaicin, piperine & curcumin following oral intake in rats. Indian J. Med. Res., 2010, 131, 682-691. [PMID: 20516541].
[83]
Cox, K.H.; Pipingas, A.; Scholey, A.B. Investigation of the effects of solid lipid curcumin on cognition and mood in a healthy older population. J. Psychopharmacol. (Oxford), 2015, 29(5), 642-651. [http://dx.doi.org/10.1177/0269881114552744]. [PMID: 25277322].
[84]
Baum, L.; Lam, C.W.; Cheung, S.K.; Kwok, T.; Lui, V.; Tsoh, J.; Lam, L.; Leung, V.; Hui, E.; Ng, C.; Woo, J.; Chiu, H.F.; Goggins, W.B.; Zee, B.C.; Cheng, K.F.; Fong, C.Y.; Wong, A.; Mok, H.; Chow, M.S.; Ho, P.C.; Ip, S.P.; Ho, C.S.; Yu, X.W.; Lai, C.Y.; Chan, M.H.; Szeto, S.; Chan, I.H.; Mok, V. Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease. J. Clin. Psychopharmacol., 2008, 28(1), 110-113. [http://dx.doi.org/10.1097/jcp.0b013e318160862c]. [PMID: 18204357].
[85]
Begum, A.N.; Jones, M.R.; Lim, G.P.; Morihara, T.; Kim, P.; Heath, D.D.; Rock, C.L.; Pruitt, M.A.; Yang, F.; Hudspeth, B.; Hu, S.; Faull, K.F.; Teter, B.; Cole, G.M.; Frautschy, S.A. Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer’s disease. J. Pharmacol. Exp. Ther., 2008, 326(1), 196-208. [http://dx.doi.org/10.1124/jpet.108.137455]. [PMID: 18417733].
[86]
Ringman, J.M.; Frautschy, S.A.; Teng, E.; Begum, A.N.; Bardens, J.; Beigi, M.; Gylys, K.H.; Badmaev, V.; Heath, D.D.; Apostolova, L.G.; Porter, V.; Vanek, Z.; Marshall, G.A.; Hellemann, G.; Sugar, C.; Masterman, D.L.; Montine, T.J.; Cummings, J.L.; Cole, G.M. Oral curcumin for Alzheimer’s disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study. Alzheimers Res. Ther., 2012, 4(5), 43. [http://dx.doi.org/10.1186/alzrt146]. [PMID: 23107780].
[87]
Hishikawa, N.; Takahashi, Y.; Amakusa, Y.; Tanno, Y.; Tuji, Y.; Niwa, H.; Murakami, N.; Krishna, U.K. Effects of turmeric on Alzheimer’s disease with behavioral and psychological symptoms of dementia. Ayu, 2012, 33(4), 499-504. [http://dx.doi.org/10.4103/0974-8520.110524]. [PMID: 23723666].
[88]
Chandra, V.; Pandav, R.; Dodge, H.H.; Johnston, J.M.; Belle, S.H.; DeKosky, S.T.; Ganguli, M. Incidence of Alzheimer’s disease in a rural community in India: the Indo-US study. Neurology, 2001, 57(6), 985-989. [http://dx.doi.org/10.1212/WNL.57.6.985]. [PMID: 11571321].
[89]
Chang, C.H.; Chen, H.X.; Yü, G.; Peng, C.C.; Peng, R.Y. Curcumin-Protected PC12 Cells Against Glutamate-Induced Oxidative Toxicity. Food Technol. Biotechnol., 2014, 52(4), 468-478. [http://dx.doi.org/10.17113/ftb.52.04.14.3622]. [PMID: 27904320].
[90]
Wang, R.; Li, Y.B.; Li, Y.H.; Xu, Y.; Wu, H.L.; Li, X.J. Curcumin protects against glutamate excitotoxicity in rat cerebral cortical neurons by increasing brain-derived neurotrophic factor level and activating TrkB. Brain Res., 2008, 1210, 84-91. [http://dx.doi.org/10.1016/j.brainres.2008.01.104]. [PMID: 18420184].
[91]
Yang, F.; Lim, G.P.; Begum, A.N.; Ubeda, O.J.; Simmons, M.R.; Ambegaokar, S.S.; Chen, P.P.; Kayed, R.; Glabe, C.G.; Frautschy, S.A.; Cole, G.M. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J. Biol. Chem., 2005, 280(7), 5892-5901. [http://dx.doi.org/10.1074/jbc.M404751200]. [PMID: 15590663].
[92]
Borchelt, D.R.; Lee, M.K.; Gonzales, V.; Slunt, H.H.; Ratovitski, T.; Jenkins, N.A.; Copeland, N.G.; Price, D.L.; Sisodia, S.S. Accumulation of proteolytic fragments of mutant presenilin 1 and accelerated amyloid deposition are co-regulated in transgenic mice. Neurobiol. Aging, 2002, 23(2), 171-177. [http://dx.doi.org/10.1016/S0197-4580(01)00280-9]. [PMID: 11804700].
[93]
Garcia-Alloza, M.; Robbins, E.M.; Zhang-Nunes, S.X.; Purcell, S.M.; Betensky, R.A.; Raju, S.; Prada, C.; Greenberg, S.M.; Bacskai, B.J.; Frosch, M.P. Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease. Neurobiol. Dis., 2006, 24(3), 516-524. [http://dx.doi.org/10.1016/j.nbd.2006.08.017]. [PMID: 17029828].
[94]
Wang, Y.; Yin, H.; Li, J.; Zhang, Y.; Han, B.; Zeng, Z.; Qiao, N.; Cui, X.; Lou, J.; Li, J. Amelioration of beta-amyloid-induced cognitive dysfunction and hippocampal axon degeneration by curcumin is associat-ed with suppression of CRMP-2 hyperphosphorylation. Neurosci Lett, 2013, 557 (Pt B), 112-117
